Ardent Health (NYSE:ARDT) Shares Gap Down – What’s Next?

Shares of Ardent Health, Inc. (NYSE:ARDT) gapped down before the market opened on Monday . The stock had previously closed at $10.11, but opened at $9.66. Ardent Health shares last traded at $10.0950, with a volume of 17,088 shares.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. UBS Group increased their price objective on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. decreased their price objective on Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 20th. Royal Bank Of Canada decreased their price objective on Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, March 9th. Finally, Leerink Partners decreased their price objective on Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. Seven analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Ardent Health currently has an average rating of “Hold” and an average target price of $14.21.

Ardent Health Stock Performance

The stock’s 50 day moving average price is $9.29 and its 200 day moving average price is $9.65. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. The company has a market cap of $1.45 billion, a price-to-earnings ratio of 10.62, a P/E/G ratio of 2.21 and a beta of 0.93.

Ardent Health (NYSE:ARDT) last issued its earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.10. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, analysts expect that Ardent Health, Inc. will post 1.12 EPS for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

Institutional investors have recently modified their holdings of the stock. Denali Advisors LLC acquired a new position in Ardent Health in the third quarter valued at approximately $2,449,000. Pier Capital LLC grew its position in shares of Ardent Health by 33.5% during the third quarter. Pier Capital LLC now owns 580,620 shares of the company’s stock worth $7,693,000 after acquiring an additional 145,703 shares during the last quarter. Vestcor Inc bought a new position in shares of Ardent Health during the fourth quarter worth about $255,000. LSV Asset Management bought a new position in shares of Ardent Health during the fourth quarter worth about $963,000. Finally, Prescott Group Capital Management L.L.C. bought a new position in shares of Ardent Health during the fourth quarter worth about $1,077,000.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.